Neurological diseases are among the most expensive and under-served healthcare challenges in Europe. Now, a Vienna-based HealthTech startup is betting that AI-powered digital therapy can help close that gap.
nyra health has announced a €20 million Series A round to expand its AI-based neurorehabilitation platform across Europe and accelerate entry into the US market.
The round was led by Armira Growth, with continued participation from existing investors Wellington Partners, Crane Venture Partners, and EVER Pharma.
The funding follows a €4.5 million Seed round in 2023, marking a significant step toward scaling what the company calls data-driven neurorehabilitation.
Tackling a €65 Billion Neurological Care Problem
The economic burden of neurological disease is enormous. In Germany alone, conditions such as stroke, dementia, and traumatic brain injuries generate an estimated €65 billion in annual costs.
Much of that expense stems from a critical gap in care: after patients leave hospitals or rehabilitation centers, therapy often becomes less frequent or stops entirely.
According to Moritz Schöllauf, closing this gap is central to the company’s mission.
“Everyone who needs therapy after a stroke or other neurological disease should have access to effective, individualised care – regardless of where they live or how strong their healthcare system is,” Schöllauf said.
The new capital will support nyra health’s expansion across the DACH region—Germany, Austria, and Switzerland—while preparing the company for entry into the US healthcare market.
AI-Powered Rehabilitation at Home
Founded in 2021, nyra health develops software designed to extend neurological therapy beyond the clinic.
At the center of its platform is myReha, an MDR Class IIa certified digital medical device that allows patients to train cognitive and speech functions from home.
The platform uses AI to analyze patient performance across several domains, including:
- speech and pronunciation
- word retrieval and language structure
- reaction times and cognitive processing
- fine motor skills and daily task performance
Therapy sessions adapt automatically based on patient progress, fatigue levels, and performance patterns, creating individualized treatment programs.
Therapists remain in the loop through nyra insights, a clinical dashboard that provides real-time data on therapy intensity, progress curves, and patient outcomes.
Already Integrated Into the Healthcare System
nyra health’s approach has already gained traction within the healthcare ecosystem.
The platform is currently used in more than 100 rehabilitation clinics and is integrated into Germany’s digital rehabilitation aftercare program run by the German Pension Insurance Fund.
Additionally, 28 health insurance providers reimburse therapy delivered through the platform, giving over 40 million insured individuals access to AI-assisted home therapy.
Clinical studies cited by the company suggest that patients using the system alongside traditional therapy show significantly greater improvements in cognitive and language functions compared with standard rehabilitation alone.
Growing Investor Interest in Neurotech
nyra health’s Series A comes amid broader investor interest in neurological innovation across Europe.
Recent funding rounds include:
- Aerska (Dublin), which raised €17M to develop RNA interference therapies targeting brain diseases
- EG 427 (Paris), which secured €27M Series B for genetic medicines addressing neurological conditions
- Strolll, which raised €12.2M for augmented-reality neurorehabilitation tools
- Neu Health, developing AI-enabled care solutions for Parkinson’s and dementia
- Hemi Health in Denmark, which raised €4M for digital therapies targeting migraine and concussion
Together, these rounds represent over €60 million in investment across neurotechnology and digital therapeutics, highlighting the growing convergence of AI, clinical care, and neuroscience.
Building the Future of Digital Neurorehabilitation
Beyond geographic expansion, nyra health plans to invest heavily in advancing its AI models.
The company is currently working on multimodal AI systems capable of supporting therapeutic interaction and diagnostics, part of a €4.2 million research initiative conducted with leading US universities.
For investors like Christian Figge, the company’s deep integration into healthcare systems makes it particularly promising.
“Neurological rehabilitation can become significantly more effective through digital solutions,” Figge said. “nyra health is considered a true category creator connecting inpatient therapy, outpatient care, and home rehabilitation.”
If successful, the startup could help establish a new model for neurological care—one where AI-powered therapy continues long after patients leave the hospital, potentially improving outcomes while reducing the massive long-term costs associated with brain disorders.
